Specific effects of γ-linolenic, eicosapentaenoic, and docosahexaenoic ethyl esters on bone post-ovariectomy in rats

Calcified Tissue International

Volumn 81, Issue 6, 2007, Pages 459-471

  Poulsen, R C ^a   Firth, E C ^b   Rogers, C W ^b   Moughan, P J ^b   Kruger, M C ^a  

^a MASSEY UNIVERSITY   (New Zealand)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Linolenic acid; Docosahexaenoic acid; Eicosapentaenoic acid; Long chain polyunsaturated fatty acids; Ovariectomy; Rats

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; DOCOSAHEXAENOIC ACID ETHYL ESTER; GAMMA LINOLENIC ACID ETHYL ESTER; ICOSAPENTAENOIC ACID ETHYL ESTER; OSTEOCALCIN; PARATHYROID HORMONE; POLYUNSATURATED FATTY ACID; SOMATOMEDIN C; UNCLASSIFIED DRUG; VITAMIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FEMUR; HORMONE DETERMINATION; LUMBAR SPINE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TIBIA;

ANIMALS; BONE AND BONES; BONE DENSITY; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; GAMMA-LINOLENIC ACID; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 37549004413     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-007-9080-7     Document Type: Article

References (46)

1. Kruger M, Horrobin D (1997) Calcium metabolism, osteoporosis and essential fatty acids. A review. Prog Lipid Res 36:131-151
2. Watkins B, Seifert M (1996) Food lipids and bone health. In: McDonald R, Min D (eds) Food lipids and health. Marcel Dekker, New York
3. Das UN (2000) Essential fatty acids and osteoporosis. Nutrition 16:386-390
4. Raisz LG, Pilbeam CC, Fall PM (1993) Prostaglandins-mechanisms of action and regulation of production in bone. Osteoporos Int 3:S136-S140
5. 2 on the growth and differentiation of osteoblast-like cells cultured in vitro. Int J Mol Med 10:451-456
6. 2 on osteoblast development in rat calvaria cell cultures. Bone 32:S139-S139
7. 2α on osteoclast formation in mouse bone-marrow cultures. J Bone Miner Res 6:157-164
8. 2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor. J Bone Miner Res 20:23-29
9. Yun AJ, Lee PY (2004) Maladaptation of the link between inflammation and bone turnover may be a key determinant of osteoporosis. Med Hypotheses 63:532-537
10. Teitelbaum SL (2004) Postmenopausal osteoporosis, T cells, and immune dysfunction. Proc Natl Acad Sci USA 101:16711-16712
11. Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton FH (1997) Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr 127:1435-1444
12. Miller CC, Tang W, Ziboh VA, Fletcher MP (1991) Dietary supplementation with ethyl-ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty-acids induces epidermal generation of local putative antiinflammatory metabolites. J Invest Dermatol 96:98-103
13. Kumar GS, Das UN, Kumar KV, Madhavi N, Das NP, Tan BKH (1992) Effect of n-6 and n-3 fatty-acids on the proliferation of human-lymphocytes and their secretion of TNF-alpha and IL-2 invitro. Nutr Res 12:815-823
14. Furse RK, Rossetti RG, Zurier RB (2001) Gamma-linolenic acid, an unsaturated fatty acid with anti-inflammatory properties, blocks amplification of IL-1 beta production by human monocytes. J Immunol 167:490-496
15. Furse RK, Rossetti RG, Seiler CM, Zurier RB (2002) Oral administration of gamma-linolenic acid, an unsaturated fatty acid with anti-inflammatory properties, modulates interleukin-10 production by human monocytes. J Clin Immunol 22:83-91
16. Decaterina R, Cybulsky MI, Clinton SK, Gimbrone MA, Libby P (1994) The omega-3-fatty-acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial-cells. Arterioscler Thromb 14:1829-1836
17. Soyland E, Lea T, Sandstad B, Drevon A (1994) Dietary supplementation with very long-chain n-3 fatty-acids in man decreases expression of the interleukin-2 receptor (Cd25) on mitogen-stimulated lymphocytes from patients with inflammatory skin diseases. Eur J Clin Invest 24:236-242
18. Danno K, Ikai K, Imamura S (1993) Antiinflammatory effects of eicosapentaenoic acid on experimental skin inflammation models. Arch Dermatol Res 285:432-435
19. Robinson DR, Xu LL, Tateno S, Guo MY, Colvin RB (1993) Suppression of autoimmune-disease by dietary n-3 fatty-acids. J Lipid Res 34:1435-1444
20. Weiss LA, Barrett-Connor E, von Muhlen D (2005) Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr 81:934-938
21. Kruger M, Coetzer H, de Winter R, Claassen N (1995) Eicosapentaenoic acid and docosahexaenoic acid supplementation increases calcium balance. Nutr Res 15:211-219
22. Kruger M, Claassen N, Schlemmer C, Coetzer H (1999) Essential fatty acid supplementation: effect on oestrogen deficiency induced bone loss in the female rat. Calcif Tissue Int 64:63
23. Weiler HA (2000) Dietary supplementation of arachidonic acid is associated with higher whole body weight and bone mineral density in growing pigs. Pediatr Res 47:692-697
24. Kruger M, Coetzer H, de Winter R, Gericke G, van Papendorp D (1998) Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging Clin Exp Res 10:385-394
25. Claassen N, Coetzer H, Steinmann C, Kruger M (1995) The effect of different n-6/n-3 essential fatty acid ratios on calcium balance and bone in rats. Prostaglandins Leukot Essent Fatty Acids 53:13-19
26. Claassen N, Potgieter HC, Seppa M, Vermaak WJH, Coetzer H, Vanpapendorp DH, Kruger MC (1995) Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats-effects on free urinary collagen cross-links, total urinary hydroxyproline, and bone calcium content. Bone 16:S385-S392
27. 2 biosynthesis, tissue IGF-I levels, and bone morphometry in chicks. J Bone Miner Res 11:1321-1332
28. Poulsen RC, Kruger MC (2006) Detrimental effect of eicosapentaenoic acid supplementation on bone following ovariectomy in rats. Prostaglandins Leukot Essent Fatty Acids 75:419-427
29. Gnudi SRG, Mongiorgi R, Fini M, Zati A, Figus E, Monti S, Ripamonti C (1993) Evaluation of an experimental model of osteoporosis induced in the female rat through ovariectomy. Boll Soc Ital Biol Sper 69:453-460
30. Kruger MC, Schollum LM (2005) Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability? Prostaglandins Leukot Essent Fatty Acids 73:327-334
31. Schlemmer C, Coetzer H, Claassen N, Kruger M (1999) Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat. Prostaglandins Leukot Essent Fatty Acids 61:381-390
32. Baggio B, Budakovic A, Nassuato MA, Vezzoli G, Manzato E, Luisetto G, Zaninotto M (2000) Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 58:1278-1284
33. Shen C-L, Yeh J, Rasty J, Li Y, Watkins B (2006) Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats. Br J Nutr 95:462-468
34. National Research Council (1995) Nutrient requirements of laboratory animals, 4th rev ed. National Academy Press, Washington DC
35. Rahman M, Bhattacharya A, Banu J, Fernandes G (2005) Reduced bone loss by docosahexaenoic acid (DHA) than eicosapentaenoic acid (EPA) in ovariectomised mice. J Bone Miner Res 20:S127
36. Li Y, Reinwald S, Seifert M, Watkins B (2003) Dietary docosahexaenoic acid supplementation maintains bone mass in ovariectomised rats. Exp Biol Abstracts B321:188.110
37. Watkins BA, Li Y, Seifert MF (2006) Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats. J Nutr Biochem 17:282-289
38. 3 by a constitutive cytochrome P-450 from rat liver microsomes. J Biol Chem 258:6777-6781
39. 3 after intravenous injection of the aqueous preparations. II: Comparative experiments on rats. Biochem Pharmacol 3:277-282
40. Nakane M, Fey TA, Dixon DB, Ma JL, Brune ME, Li YC, Wu-Wong JR (2006) Differential effects of vitamin D analogs on bone formation and resorption. J Steroid Biochem Mol Biol 98:72-77
41. Sakaguchi K, Morita I, Murota S (1994) Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats. Prostaglandins Leukot Essent Fatty Acids 50:81-84
42. Leonard F, Haag M, Kruger M (2001) Modulation of intestinal vitamin D receptor availability and calcium ATPase activity by essential fatty acids. Prostaglandins Leukot Essent Fatty Acids 64:147-150
43. Brandi M, Fitzpatrick L, Coon H, Aurbach G (1986) Bovine parathyroid cells: cultures maintained for more than 140 population doublings. Proc Natl Acad Sci USA 83:1709-1713
44. 2 or indomethacin on serum parathyroid hormone and calcitonin in the rat. Prostaglandins Med 6:641-645
45. Qin L, Raggatt LJ, Partridge NC (2004) Parathyroid hormone: a double-edged sword for bone metabolism. Trends Endocrinol Metab 15:60-65
46. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A (1997) Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961-2970